Osteal Therapeutics Closes $23M Series C Financing

Financing led by Asteroid Partners with new investor Gideon Strategic Partners and returning investors Johnson and Johnson Development Corp., HM Capital,...

Related Keywords

Dallas ,Texas ,United States ,Steven Sands ,David Thompson ,Martin Sands ,Todd Saunders ,Johnson Development Corp ,Drug Administration ,Osteal Therapeutics Inc ,Johnson Development Corporation ,Asteroid Partners ,Gideon Strategic Partners ,Prism Ventures ,New Drug Application ,Chief Executive ,Periprosthetic Joint Infection ,Osteal Therapeutics ,